Diabetic Retinopathy Screening in General Practice
Launched by AALBORG UNIVERSITY · Mar 9, 2022
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with type 2 diabetes
- • Understands Danish
- • Age between 18-70
- Exclusion Criteria:
- • Blindness
- • Cannot partake in second screening
About Aalborg University
Aalborg University is a leading research institution based in Denmark, renowned for its innovative approach to education and research in engineering, natural sciences, and health sciences. With a commitment to advancing knowledge and improving public health outcomes, Aalborg University actively engages in clinical trials that explore cutting-edge medical solutions and interventions. The university fosters interdisciplinary collaboration, leveraging its expertise to enhance clinical research methodologies and contribute to the development of evidence-based practices in healthcare. Through its rigorous scientific inquiry and dedication to ethical standards, Aalborg University plays a pivotal role in shaping the future of health research and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, Dk, Denmark
Patients applied
Trial Officials
Malene Krogh
Principal Investigator
Aalborg University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials